NPFCX
Price
$60.26
Change
+$0.31 (+0.52%)
Updated
Jan 22 closing price
Net Assets
146.92B
PAGSX
Price
$65.14
Change
+$0.56 (+0.87%)
Updated
Jan 22 closing price
Net Assets
7.05B
Ad is loading...

NPFCX vs PAGSX

Header iconNPFCX vs PAGSX Comparison
Open Charts NPFCX vs PAGSXBanner chart's image
American Funds New Perspective C
Price$60.26
Change+$0.31 (+0.52%)
VolumeN/A
Net Assets146.92B
T. Rowe Price Global Stock Adv
Price$65.14
Change+$0.56 (+0.87%)
VolumeN/A
Net Assets7.05B
NPFCX vs PAGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPFCX vs. PAGSX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and PAGSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 147B vs. PAGSX (7.05B). NPFCX pays higher dividends than PAGSX: NPFCX (0.20) vs PAGSX (0.08). NPFCX was incepted earlier than PAGSX: NPFCX (24 years) vs PAGSX (19 years). PAGSX is a more actively managed with annual turnover of: 102.50 vs. NPFCX (17.00). NPFCX has a lower initial minimum investment than PAGSX: NPFCX (250) vs PAGSX (2500). PAGSX (15.41) and NPFCX (15.26) have marching annual gain over last year. PAGSX return over 5 years is better than : 38.63 vs. NPFCX (30.44).
NPFCXPAGSXNPFCX / PAGSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years19 years-
Gain YTD4.0765.81570%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets147B7.05B2,084%
Annual Yield % from dividends0.200.08261%
Returns for 1 year15.2615.4199%
Returns for 3 years5.8413.7642%
Returns for 5 years30.4438.6379%
Returns for 10 years69.40156.1444%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR1.690.07
+4.32%
Heartcore Enterprises
PEBO32.200.85
+2.71%
Peoples Bancorp
CLVT5.440.08
+1.49%
Clarivate Plc
CRDF3.540.02
+0.57%
Cardiff Oncology
CQP60.51-2.28
-3.63%
Cheniere Energy Partners LP